| Good Life Medical Group, Inc. | |
|
3650 South St Ste 204 Lakewood CA 90712-1521 | |
| (562) 602-8841 | |
| (562) 602-8843 |
| Full Name | Good Life Medical Group, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 3650 South St, Lakewood, California |
| Authorized Official Name and Position | Peter Hugh (C.E.O.) |
| Authorized Official Contact | 5626028841 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Good Life Medical Group, Inc. 3650 South St Ste 204 Lakewood CA 90712-1521 Ph: (562) 602-8841 | Good Life Medical Group, Inc. 3650 South St Ste 204 Lakewood CA 90712-1521 Ph: (562) 602-8841 |
| NPI Number | 1316940828 |
|---|---|
| Provider Enumeration Date | 05/31/2005 |
| Last Update Date | 11/14/2010 |
| Medicare PECOS PAC ID | 0749188456 |
|---|---|
| Medicare Enrollment ID | O20031219000386 |
News Archive
Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).
In a finding that runs counter to most health disparities research, Johns Hopkins researchers say that while younger black trauma patients are significantly more likely than whites to die from their injuries, black trauma patients over the age of 65 are 20 percent less likely to do so.
Glucose intolerance or insulin resistance do not appear to be associated with pathological features of Alzheimer disease (AD) or detection of the accumulation of the brain protein β-amyloid (Αβ), according to a report published by JAMA Neurology, a JAMA Network publication.
Researchers have found significant differences in brain development in infants as young as six months old who later develop autism, compared with babies who don't develop the disorder.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316940828 | NPI | - | NPPES |
| GR0092320 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20A6005 (California) | Primary |
| 208000000X | Pediatrics | A050818 (California) | Secondary |
| Provider Name | Peter Chiusing Hugh |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316035082 PECOS PAC ID: 6901704626 Enrollment ID: I20110214000482 |
News Archive
Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).
In a finding that runs counter to most health disparities research, Johns Hopkins researchers say that while younger black trauma patients are significantly more likely than whites to die from their injuries, black trauma patients over the age of 65 are 20 percent less likely to do so.
Glucose intolerance or insulin resistance do not appear to be associated with pathological features of Alzheimer disease (AD) or detection of the accumulation of the brain protein β-amyloid (Αβ), according to a report published by JAMA Neurology, a JAMA Network publication.
Researchers have found significant differences in brain development in infants as young as six months old who later develop autism, compared with babies who don't develop the disorder.
› Verified 8 days ago
News Archive
Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).
In a finding that runs counter to most health disparities research, Johns Hopkins researchers say that while younger black trauma patients are significantly more likely than whites to die from their injuries, black trauma patients over the age of 65 are 20 percent less likely to do so.
Glucose intolerance or insulin resistance do not appear to be associated with pathological features of Alzheimer disease (AD) or detection of the accumulation of the brain protein β-amyloid (Αβ), according to a report published by JAMA Neurology, a JAMA Network publication.
Researchers have found significant differences in brain development in infants as young as six months old who later develop autism, compared with babies who don't develop the disorder.
› Verified 8 days ago
Prohealth Partners, A Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3650 E. South St., Suite 212, Lakewood, CA 90712 Phone: 562-299-5200 | |
Lakewood Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4318 South St, Lakewood, CA 90712 Phone: 562-788-7574 Fax: 562-788-7650 | |
Prohealth Partners, A Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Downey Ave Ste 202, Lakewood, CA 90712 Phone: 562-634-4939 Fax: 562-634-5809 | |
Zuberi Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3514 E South St, Lakewood, CA 90712 Phone: 310-908-9338 Fax: 562-808-2145 | |
Prohealth Partners, A Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3650 South St, Suite 210, Lakewood, CA 90712 Phone: 562-630-0910 Fax: 562-630-4877 | |
Jesse J Licuanan Md A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3300 E South St, Suite 205, Lakewood, CA 90805 Phone: 562-531-0377 Fax: 562-531-1724 | |
Planned Parenthood Los Angeles-lakewood Center Basic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5519 Del Amo Blvd, Lakewood, CA 90713 Phone: 213-284-3126 Fax: 562-867-6846 |